期刊文献+

霍乱毒素B亚单位与志贺毒素2B亚单位融合表达及抗原性检测

Clone and express ctb-stx2b fusion gene in Enterohemrrhagic escherichia coli O157 : H7 Shigeai toxin 2B subunit and V cholera toxin B subunit and the detection of their immunogenicity
原文传递
导出
摘要 目的克隆表达出血性大肠埃希菌(EHEC)O157:H7志贺毒素2B亚单位(Stx2B)与霍乱毒素B亚单位(CTB)的融合蛋白(CTB-Stx2B),并检测其抗原性和与神经节苷脂(GM1)结合能力。方法设计引物扩增融合蛋白CTB—Stx2B的编码基因ctb-stx2b,T-A克隆测序验证后克隆入原核表达质粒pET30a(+)C,构建表达质粒pET30a(+)-ctb-stx2b,转化E.coliBL21(DE3),IPTG诱导表达、纯化,获得目的蛋白CTB-Stx2B,SDS-PAGE和Western-blot检测其抗原性和形成五聚体的能力;GMI-ELISA法检测其与GM1结合能力。结果扩增出约750bp的目的片段,测序鉴定与设计序列一致;原核表达质粒pET30a(+)-ctb-stx2b转化E.coliBL21(DE3)后,经酶切和PCR扩增鉴定正确;IPTG诱导后SDS-PAGE初步测定CTB-Stx2B单体的相对分子质量(Mr)约为20×10^3;Western-blot检测CTB-Stx2B能与CTB单克隆抗体结合,纯化产物经复性后大多以五聚体形式存在;ELISA检测CTB-Stx2B具有结合GM1活性。结论成功克隆、表达了融合蛋白CTB-Stx2B;表达的蛋白具有良好的CTB抗原性和GM1结合能力。 Objective To clone and express the fusion gene encoding Enterohemrrhagic escherichia coli O157:H7 (EHEC O157 : H7) Shigela toxin 2B subunit (Stx2B) and vibrio cholera toxin B subunit (CTB) as well as to detect the immunogenicity and GM1-binding ability of fusion protein. Methods To design a primer to amplify stx2b gene and ctb-stx2b fusion gene encoding Stx2B and CTB-Stx2B respectively and to clone the genes into express plasmid pET30a( + )C in order to construct pET3Oa-ctbstx2b after T-A sequencing was varified, then to transform constructed plasmid into E. coliBL21 (DE3) induced by IPTG and purified by a purify kit and to detect molecular weight and immunogenicity by SDSPAGE and Western-blot. Results The amplified ctb-stx2b fragments appeared to be 750 bp and gene sequence was identical to designed sequence. The prokaryotic expression system pET3Oa-ctb-stx2b/BL21 could express protein weight about Mr 20×10^3 and the expressed protein could react to CTB monoclone anti-body. The fusion protein CTB-Stx2B could bind GM1. Conclusion CTB-Stx2B had successfully been expressed in prokaryotic while the expressed protein had good immunogenicity and GM1-Binding ability. This study provided information on further EHEC O157:H7 vaccine research.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2008年第4期378-382,共5页 Chinese Journal of Epidemiology
关键词 肠出血性大肠埃希菌O157:H7 志贺毒素2B亚单位 霍乱毒素B亚单位 抗原性 Enterohernrrhagic escherichia coli O157:H7 Shiga toxin 2B subunit Cholera toxin B subunit Immunogenicity
  • 相关文献

参考文献11

  • 1Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med, 1983,308 : 681-685.
  • 2Bell BP, Griffin PM, Lozano P, et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157 infections. Pediatrics,1997,100(1) :E12.
  • 3Paola M, George M, Randy JR, et al. Immunoprophylactic potential of cloned Shiga toxin 2B subunit. J Infect Dis, 2001,183 : 435-443.
  • 4Gonzalea RA, Sanehez J, Holmgren J, et al. Immunological eharaeterization of a rotavirus neutralizing epitope fused to the cholera toxin B subunit. Gene, 1993,133:227.
  • 5Czerkinsky C, Russekk MW, Lycke N, et al. Oral administration of a streptococcal antigen coupled to cholera toxin B subunite evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun, 1989,57 (4) : 1072.
  • 6徐建国,程伯鲲,冯丽萍,景怀琦,杨晋川,赵广法,汪华,李洪卫.肠出血性大肠埃希菌O157∶H7引起的溶血性尿毒综合征患者血清抗体调查[J].中华流行病学杂志,2002,23(2):114-118. 被引量:25
  • 7Konadu EY,Donohue Rolfe A, Calderwood SB, et al. Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice. Infect Immun, 1999,67(11) :6191-6193.
  • 8Konadu EY, Robbins JB, Shiloach J, et al. Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide protein conjugate vaccines. Infect Immun,1994,62(11) :5048-5054.
  • 9周志江.肠出血性大肠杆菌O157[M].北京:军事医学科学出版社,2002..
  • 10刘相国,杨恭,邱并生,田波.乙肝表面抗原a表位粘膜疫苗的构建及免疫原性检测[J].微生物学报,2001,41(5):625-629. 被引量:1

二级参考文献14

  • 1董自正,张兆山,李淑琴,张蓓宁,黄翠芬.人源肠毒素大肠杆菌CS3纤毛基因的克隆及表达[J].中华微生物学和免疫学杂志,1994,14(2):84-88. 被引量:15
  • 2徐建国,祁国明.肠出血性大肠杆菌的临床、检测方法和流行病学特征[J].中华流行病学杂志,1996,17(6):367-369. 被引量:45
  • 3Gaastra W, Svennerholm A M. Colonization factors of human enterotoxigenic Escherichia coli ( ETEC ). Trends in Microbioi,1996, 4 (11): 444~452.
  • 4WHO. New frontiers in the development of vaccines agaist enterotoxingenic (ETEC) and enterohaemorrhagic, (EHEC) E.coli infections. Weekly Epidemiological Record. 1999, (3): 98--101.
  • 5Qadri F, Wermeras C, Ahmed F, et al. Safety and immunogenicity of an oral, inactivated enterotoxiganic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children. Vaccine, 2000, 18 (24): 2704--2712.
  • 6Sanchez J, Johansson S, Lowenadler B, et al. Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination. Res Microbiol, 1990, 141 (8--9): 971--979.
  • 7Shi C H, Cao C, Zhig J S, et al. Gene fusion of cholear toxin B subunit and HBV PreS2 epitope and the antigenicity of fusion protein. Vaccine, 1995, 13 (10): 933~937.
  • 8Sambrook J, Russell D W. Molecular Cloning: A Laboratory Manual. 3th. New York: Cold Spring Harbor Laboratory Press,2001. 34--69.
  • 9Jagnsztyn-Krynicka E K, Clark-Curtiss J E, Curtiss R 3rd .Escherichia coli heat-labile toxin subtmit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activitese of the hybrid proteins. Infect Immun, 1993, 61 (3): 1004--1015.
  • 10Liljeqvist S, Stahl S, Andreoni C, et al. Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding. J Immun Meth, 1997, 210 (2): 125--135.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部